| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/04/2022 | 182.05% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
| 05/04/2022 | 207.69% | B. Riley Securities | $7 → $6 | Maintains | Buy |
| 05/04/2022 | 361.54% | HC Wainwright & Co. | $13 → $9 | Maintains | Buy |
| 09/17/2020 | 669.23% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 09/01/2020 | 669.23% | SVB Leerink | → $15 | Initiates Coverage On | → Outperform |
| 05/06/2020 | 720.51% | B. Riley Securities | $12 → $16 | Maintains | Buy |
| 05/06/2020 | 617.95% | HC Wainwright & Co. | $13 → $14 | Maintains | Buy |
CytoSorbents Questions & Answers
The latest price target for CytoSorbents (NASDAQ: CTSO) was reported by HC Wainwright & Co. on November 4, 2022. The analyst firm set a price target for $5.50 expecting CTSO to rise to within 12 months (a possible 182.05% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for CytoSorbents (NASDAQ: CTSO) was provided by HC Wainwright & Co., and CytoSorbents maintained their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on November 4, 2022 so you should expect the next rating to be made available sometime around November 4, 2023.
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a maintained with a price target of $9.00 to $5.50. The current price CytoSorbents (CTSO) is trading at is $1.95, which is out of the analyst's predicted range.